GlassScriptPhysician profile
Jerry Spivak
NPI 1083645303
$98,248.24
in general payments reported to CMS, 2019-2025
5 companies · $7,875 in 2025
The $7,875 reported for 2025 was more than what a typical Hematology (Internal Medicine) provider received nationally (typical 2025 total: $1,177).
See the full distribution for Hematology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $11K · 2021: $11K · 2022: $15K · 2023: $21K · 2024: $5,250 · 2025: $7,875.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $27K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,781 · Food and Beverage: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $27,075.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,781.25 |
| Food and Beverage | $124.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $74,776.46 | 2019-2025 | |
| Pharmaessentia USA Corporation | $10,906.24 | 2022-2023 | Besremi |
| Celgene Corporation | $4,874.37 | 2019 | |
| Abbvie INC. | $4,256.78 | 2019 | |
| Glaxosmithkline, LLC. | $3,434.39 | 2022-2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Spivak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.